T. Rowe Price Investment Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$173M Buy
+1,622,675
New +$196M 0.11% 201
2026
Q1
Sell
-61
Closed -$11K 791
2025
Q4
$11K Buy
61
+7
+13% +$1.28K ﹤0.01% 707
2025
Q3
$8K Buy
+54
New +$6.62K ﹤0.01% 732
2025
Q2
Sell
-1,476,948
Closed -$113M 713
2025
Q1
$113M Sell
1,476,948
-505,759
-26% -$38.7M 0.07% 257
2024
Q4
$137M Sell
1,982,707
-294,436
-13% -$21.2M 0.08% 238
2024
Q3
$166M Sell
2,277,143
-158,819
-7% -$11.7M 0.1% 211
2024
Q2
$163M Sell
2,435,962
-1,015,618
-29% -$39.4M 0.1% 200
2024
Q1
$93.6M Sell
3,451,580
-2,399,026
-41% -$67.1M 0.06% 297
2023
Q4
$181M Sell
5,850,606
-2,474,278
-30% -$64.2M 0.12% 197
2023
Q3
$210M Buy
8,324,884
+20,570
+0.2% +$470K 0.15% 169
2023
Q2
$175M Sell
8,304,314
-111,116
-1% -$2.11M 0.12% 193
2023
Q1
$143M Buy
8,415,430
+40,755
+0.5% +$792K 0.1% 203
2022
Q4
$167M Buy
8,374,675
+307,913
+4% +$5.95M 0.13% 175
2022
Q3
$174M Buy
+8,066,762
New +$193M 0.14% 158

Other funds holding INSM

T. Rowe Price Investment Management's INSM Position: Q2 2026 in Review

T. Rowe Price Investment Management opened a new position in Insmed (INSM) in Q2 2026: 1,622,675 shares worth $173M. The stake represents 0.11% of the portfolio and ranks #201 among its holdings. This is a return to the name: T. Rowe Price Investment Management previously reported a position in INSM as recently as Q4 2025.

T. Rowe Price Investment Management first reported a position in INSM in Q3 2022 and has held it in 14 quarters since. The position peaked at $210M in Q3 2023. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • T. Rowe Price Investment Management held 1,622,675 shares of Insmed worth $173M as of Q2 2026.
  • Insmed was a new T. Rowe Price Investment Management position in Q2 2026.
  • Insmed made up 0.11% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #201 holding.
  • T. Rowe Price Investment Management first reported a position in Insmed in Q3 2022 and has held it in 14 quarters since.
  • T. Rowe Price Investment Management's Insmed position peaked at $210M in Q3 2023.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.